OurCrowd (Investment in Site Diagnostics) L.P. — Form D
OurCrowd (Investment in Site Diagnostics) L.P. of Jerusalem, L3, a pooled investment fund, filed a Form D exempt-offering notice with the SEC on 2020-06-18. $11K was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2020-06-18
- Form: D
- Accession: 0001599504-20-000004
- Industry: Pooled Investment Fund
- Exemptions: 06c, 3C, 3C.1
- Amount sold: $11K
- Minimum investment: $10K
- Investors: 1
- Date of first sale: 2020-05-18
- Security types: fund interests
- Revenue range: No Revenues
- SEC file number: 021-369187
Issuer
- Name: OurCrowd (Investment in Site Diagnostics) L.P.
- CIK: 0001609303
- Entity type: Limited Partnership
- Jurisdiction: VIRGIN ISLANDS, BRITISH
- Incorporated: 2014
- Address: 28 Derech Hebron, Jerusalem, L3, 9108001
- Phone: 972-2-636-9300
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Andrew Kaye | Director | Jerusalem, L3 |
| Jonathan Medved | Director | Jerusalem, L3 |
| Cali Chill | Executive Officer | JERUSALEM, L3 |
| Robert Citron | Executive Officer | Jerusalem, L3 |
| Andrew Kaye | Executive Officer | Jerusalem, L3 |
| Jonathan Medved | Executive Officer | Jerusalem, L3 |
| Jay Kalish | Executive Officer | Jerusalem, L3 |
| Steven Blumgart | Director | Jerusalem, L3 |
| Steven Blumgart | Executive Officer | Jerusalem, L3 |
Other filings by this issuer (4)
More